Apollo Hospitals and Medtronic Partner to Advance Stroke Management Using Artificial Intelligence (AI)
- Medtronic will
support Apollo Hospitals with technical expertise, training and setting up of
comprehensive stroke centers aiming at reducing door to needle time
- Apollo Hospitals, with one of the largest
Neuro care team in South Asia to use AI in an organized and scalable manner for
comprehensive stroke management
National, October 29, 2020: Apollo Hospitals Group today
announced a partnership with India Medtronic Private Limited, a wholly owned
subsidiary of Medtronic plc (NYSE: MDT) to integrate artificial intelligence
(AI) for advanced stroke management for the first time in India. The USFDA
approved AI platform for stroke diagnosis has been validated by clinical
trials. The AI software will provide automated analysis in less than two
minutes, enabling faster decision making in stroke where every second counts. Through
this partnership, Medtronic will help in bringing in stroke technologies, technical
expertise, training and comprehensive stroke management with the integration of
AI platform at the Apollo Institute of Neurosciences at ten locations in Apollo
Hospitals across the country, taking stroke management to the next level by
standardizing stroke diagnosis and empowering clinicians to make faster, more
accurate diagnosis and treatment decisions.
Dr. Prathap C
Reddy, Chairman, Apollo Hospitals Group
said, “Stroke is a major global public health problem with 1 in 4 people over
the age of 25 years suffering a stroke during their lifetime, according to
data from the World Stroke Organization. The fourth leading cause of death
today, around 1.8 million people in India suffer from a stroke every year and
it is only early treatment that can reduce morbidity and mortality. There is an
urgent need to improve the treatment and management of stroke using digital
technologies. Today, AI platforms are improving patient care and outcomes every
day, and at Apollo Hospitals, we are proud to be at the forefront of the AI
revolution in healthcare. This partnership brings together Apollo Hospitals’
clinical expertise, AI platform and stroke technologies from Medtronic to
transform stroke treatment in the country. With this partnership, Apollo
Hospitals continues to be the torchbearer in adoption of digital technology as one
of the first hospital group in South Asia to use AI in an organized and
scalable manner for comprehensive stroke management. Also, with the
introduction of 640 slice CT Scan having a capability of doing cerebral
angiogram, the patient will definitely gain by means of advanced technical
adaptations in stroke treatment. AI has been a boon for the healthcare industry
and has transformed many different aspects from drug development to diagnostics
and clinical medicine and surgery. It has simplified the lives of patients,
doctors and hospital administrators, taking over tasks that are routine, saving
time and costs, freeing the doctors to give more time to their patients. It has
helped to reduce the chances of errors in diagnostic processes and medical
errors due to heavy caseloads.”
Mr. Madan Krishnan, Vice President, Medtronic Indian Subcontinent said, “Medtronic
has been leading the fight against acute ischemic stroke (AIS) – enabling our
physician partners with meaningful stroke technologies to empower their
expertise. There is a huge unmet need with regards to stroke awareness and
therapy in India. Medtronic has been partnering with hospitals to create
centers of excellence in the country so that patients are identified faster,
and they receive the best treatment. We are aiming to address the current
treatment gaps in stroke with our innovative technologies, aiming at reducing
door to needle time, thereby potentially improving outcomes for patients. Our
partnership with Apollo Hospitals will further our goal of creating awareness
and providing quicker access to quality healthcare for stroke patients in
India.”
The AI platform uses artificial
intelligence to create high quality, advanced images from non-contrast CT, CT
angiography, CT perfusion, and MRI diffusion and perfusion scans, helping
hospitals to improve time-critical triage or transfer decisions and facilitate
better patient outcomes. The stroke team will be able to remotely access the
brain scans of stroke patients with the AI analysis on mobile app or email for faster
decision making without losing time. Other benefits include physicians being able
to evaluate the patients remotely and visit in-person only when the AI analysis
of the scans suggest indication for treatment. This will help to reduce
unnecessary exposure in a COVID situation. The AI system will also generate a
valid document proof to support the clinician’s decision taken on the course of
treatment for a stroke patient.
Ms. Preetha Reddy, Vice Chairperson,
Apollo Hospitals Group said, “The
Apollo Hospitals – Medtronic partnership will bring about a paradigm shift in
acute stroke management, building and establishing a world-class stroke program
with uniform stroke protocol across the group. Trials have shown success in
achieving substantially larger clinical benefits through the use of AI
technology and the Apollo – Medtronic partnership will support early diagnosis
and effective clinical decision in stroke patients leading to the shortest
treatment time for better clinical outcomes. While early treatment leads to the
best clinical outcome, a trial of stroke patients treated up to 6 to 24 hours
with use of AI technology lead CTP or MRI scans showed better clinical outcomes
for the patients. The partnership also envisages a structured training and
education program to further improve the clinical efficiency of the Apollo
stroke clinicians and support team.”
The Apollo
Hospitals and Medtronic partnership to build comprehensive stroke management
will lead to multiple patient benefits. The use of AI platform in stroke
management will reduce diagnosis time from 60 minutes to 2 minutes The time
saved is brain cells saved as every minute of delay leads to 2 million more
brain cells dying. A stroke at odd hours of night will not result in patient
losing time for an expert review to begin treatment. Time between onset of
stroke to treatment is significantly reduced which can help in improving
outcome, reducing hospital stay and saving costs for the patient not just on
hospitalization but also on follow-up and rehabilitation. Every patient will
receive appropriate treatment as per the indication and not lose any treatment
opportunity.
Ms. Suneeta Reddy, Managing Director,
Apollo Hospitals Group said, “The
Apollo Institute of Neurosciences has revolutionized high-end neurological care
in the country. With a legacy of innovation and excellence, it has been working
at the cutting-edge of neuro-imaging, neuro-intensive care and medical and
radiation oncology services to deliver outcomes that match the leading
neurology institutions in the world. A highly skilled multidisciplinary
neurosciences team dedicates itself to enhancing patient care through cutting
edge technology and the partnership with Medtronic will elevate the quality of
stoke care with world-class AI-powered stroke treatment.”
Apollo Hospitals’
comprehensive stroke center equipped with 24/7 emergency, a team of specialized
experts, CT, MRI facility, and capability of specialized surgical and
interventional therapies will have treatment taken to the next level through
AI. With AI technology, stroke diagnosis will be standardized and scans will be
available remotely within no time to the stroke physician. The technology will increase
utilization of IV-tPA (intravenous thrombolysis for acute ischemic stroke). It
will also increase detection of LVO (large vessel occlusion) which accounts for
up to 38% of acute ischemic strokes and utilization of mechanical thrombectomy
(physical removal of the clot in the brain by a special device threaded through
the blood vessels). The partnership will optimize stroke protocol and create a
strong regional tele-stroke network with the power of AI.
The AI technology
enabled advanced stroke management will be launched at the Apollo Institute of
Neurosciences at Apollo Hospitals, Bannerghatta Road, Bengaluru; Apollo
Hospitals, Greams Road, Chennai; Apollo Hospitals Navi Mumbai; Apollo
Hospitals, Ahmedabad; Apollo Hospitals, Jubilee Hills, Hyderabad; Indraprastha
Apollo Hospitals, New Delhi; Apollo Speciality Hospitals, Jayanagar, Bengaluru;
Apollo Hospitals, Sheshadripuram, Bengaluru; Apollo BGS Hospitals, Mysore; and
Apollo Hospitals, Indore.
About Apollo Hospitals:
Apollo Hospitals
was established in 1983 by Dr. Prathap C Reddy, renowned as the architect of
modern healthcare in India. As the nation’s first corporate hospital, Apollo
Hospitals is acclaimed for pioneering the private healthcare revolution in the
country. Apollo Hospitals has emerged as Asia’s foremost integrated healthcare
services provider and has a robust presence across the healthcare ecosystem,
including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and
several retail health models. Since its inception, Apollo Hospitals has been
honoured by the trust of over 150 million individuals who came from 140
countries. At the core of Apollo’s patient-centric culture is TLC (Tender
Loving Care), the magic that inspires hope amongst its patients.
For further
details, log onto: www.apollohospitals.com
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland,
is among the world’s largest medical technology, services and solutions
companies – alleviating pain, restoring health and extending life for millions
of people around the world. Medtronic employs more than 90,000 people
worldwide, serving physicians, hospitals and patients in more than 150 countries.
The company is focused on collaborating with stakeholders around the world to
take healthcare Further, Together.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic reports on file
with the Securities and Exchange Commission. Actual results may differ
materially from anticipated results.
References-
1 https://www.rapidai.com/trial-results
2 https://www.world-stroke.org/world-stroke-day-campaign
3 Guidelines for
Prevention and Management of Stroke by Ministry of Health and Family Welfare,
Government of India, 2019
4 Sweid A, Hammoud B, Ramesh S,
et al Acute ischaemic stroke interventions: large vessel occlusion and beyond
Stroke and Vascular Neurology 2020;5:doi: 10.1136/svn-2019-000262
For More
information please contact:
Sye Nihalani: +91 98906 98932: sye.nihalani@adfactorspr.com
Rohan Talukdar:
+91 8689826350: rohan.talukdar@adfactorspr.com
Saurabh Bose: +91
7275798384: saurabh_bose@apollohospitals.com
For Medtronic:
Zoya Ghosh: +91
9769945616: ZGhosh@CurrentGlobal.com
Raunak Narayanan: +91 7738054504: RNarayanan@CurrentGlobal.com
Masooma Pathre, Public Relations: +91 98197 44665: masooma.pathre@medtronic.com
Ryan Weispfenning, Investor Relations: +1-763-505-4626
Post a Comment